Target intelligence / Profile preview

Proteasome subunit alpha type-1 (PSMA1)

Target
PSMA1
Molecular classification
Enzyme, Peptidase, Proteasome core subunit
01

Overview

Proteasome subunit alpha type-1 (PSMA1) is an essential component of the 20S proteasome core complex, playing a structural and regulatory role in cellular protein degradation through the ubiquitin-proteasome pathway. As part of the multicatalytic complex, it contributes to forming the alpha-ring gating system that controls substrate entry into the internal proteolytic chamber. The 20S core, together with regulatory particles (such as 19S, 11S), mediates ATP-dependent and independent cleavage of polyubiquitinated, misfolded, or damaged proteins, thus ensuring cellular protein quality control, regulating cell cycle, apoptosis, and immune functions (particularly antigen presentation via MHC class I). PSMA1 has gained interest as a cancer target due to its overexpression and oncogenic roles in several solid tumors and hematologic malignancies, notably mediating cancer cell proliferation, migration, invasion, and resistance to therapy. Drugs targeting the proteasome, like bortezomib and carfilzomib, are used therapeutically in multiple myeloma and other cancers. However, inhibition of proteasome activity is associated with significant side effects and the emergence of therapeutic resistance. Elevated PSMA1 expression is associated with poor prognosis in cancers such as gastric and colon cancer, and its detection can serve as a biomarker for tumor burden.

Other names
Proteasome 20S subunit alpha 120S proteasome subunit alpha-6HC2NUPROS30PSC2PROS-30alpha-6MGC14542MGC14575MGC14751MGC1667MGC21459MGC22853MGC2391530 kDa prosomal proteinMacropain subunit C2Multicatalytic endopeptidase complex subunit C2Proteasome component C2Proteasome nu chainProteasome subunit alpha-6proteasome subunit α6HEL-S-275epididymis secretory protein Li 275macropain subunit nuprotein P30-33Ktesticular tissue protein Li 150
02

Mechanism of action

Inhibition of proteasomal protein degradation; Disruption of ubiquitin-proteasome pathway; Stabilization/accumulation of regulatory proteins (e.g., pro-apoptotic proteins, cell cycle proteins)

03

Biological functions

Proteolytic degradation of intracellular proteinsATP/ubiquitin-dependent proteolysis (non-lysosomal)Maintenance of protein homeostasisImmune response (MHC class I antigen processing)Cell cycle regulationApoptosisRegulation of metabolic processes
04

Disease associations

Cancer (oncogenic role, tumor progression)Neurodegenerative diseasesInflammationCystic fibrosisThyroid hemiagenesis
05

Safety considerations

Proteasome inhibition leads to broad cellular effects, including toxicity in non-cancerous tissuePotential for peripheral neuropathy and immunosuppression (seen with proteasome inhibitors)Resistance mechanisms and compensatory upregulation in tumor cells
06

Interacting drugs

Bortezomib

2 more in the full profile.

07

Biomarkers

Upregulation linked to poor prognosis in certain cancers (e.g., gastric and colon cancer)Serum protein detection in metastatic cancer

Beyond the preview

Go deeper on Proteasome subunit alpha type-1 (PSMA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome subunit alpha type-1 (PSMA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call